Acrux Ltd
ASX:ACR
Gross Margin
Acrux Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| AU |
|
Acrux Ltd
ASX:ACR
|
6.1m AUD |
100%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
83%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
56%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
490.6B USD |
68%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
74%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.4B GBP |
82%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
197.5B CHF |
76%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
243.2B USD |
79%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
82%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
202B USD |
68%
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
142.4B USD |
75%
|
Acrux Ltd
Glance View
Acrux Ltd. operates as a pooled development fund that invests in pharmaceutical businesses. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-09-29. The firm is engaged in developing and commercializing a portfolio of generic topical prescription pharmaceutical products which use dermal and transdermal drug delivery technology. The firm's product pipeline includes Evamist, Lenzetto, Jublia, EMLA and Testosterone Topical Solution. The firm's transdermal or topical pharmaceutical product portfolio can be segregated into approximately two streams, such as generic pharmaceutical products and specialty pharmaceutical products. The products offered by the Company are the testosterone topical solution to treat adult males who have low or no testosterone and Estradiol MDTS to treat moderate to severe hot flushes commonly associated with menopause. The company is also developing a range of topical and dermatological generic products for the United States market. The firm operates in the United States, Europe and other markets.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Acrux Ltd's most recent financial statements, the company has Gross Margin of 100%.